Abstract PS15-01: A First-in-human Phase 1 Study of SIM0270, a Brain-Penetrant Oral Selective Estrogen Receptor Degrader (SERD), in Patients with ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要